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Background: The purpose of this study was to evaluate the efficacy of prenatal ultrasonography and Doppler
sonography in detecting isolated ventricular septal defects (VSDs) in a late-second-trimester population.
Methods: Fetal echocardiography, Doppler ultrasound, and biometry were used to evaluate 2,661 singleton fetuses
(1,381 male fetuses and 1,280 female fetuses) between 1 August 2006 and 31 May 2010. The efficacy of each fetal
biometry, Doppler ultrasound, and nasal bone length (NBL) measurement was evaluated in all of the fetuses. A
standard fetal echocardiographic evaluation, including two-dimensional gray-scale imaging and color and Doppler
color flow mapping, was performed on all fetuses.
Results: We detected isolated VSDs in 124 of the 2,661 singleton fetuses between 19 and 24 weeks of gestation.
The prevalence of isolated VSDs in the study population was 4.66%. A multiple logistic regression analysis indicated
that short fetal NBL (odds ratio = 0.691, 95% confidence interval: 0.551 to 0.868) and the pulsatility index (PI) of the
umbilical artery (odds ratio = 8.095, 95% confidence interval: 4.309 to 15.207) and of the middle cerebral artery
(odds ratio = 0.254, 95% confidence interval: 0.120 to 0.538) are significantly associated with isolated VSDs.
Conclusion: Late-second-trimester fetal NBL, umbilical artery PI, and middle cerebral artery PI are useful parameters
for detecting isolated VSDs, and can be used to estimate the a priori risk of VSDs in women at high risk and at low
risk of isolated VSDs.
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Prenatal ultrasound screening is widely employed for
detecting congenital malformations and structural heart
defects. In previous studies, the prevalence of fetal
congenital heart disease (CHD) ranged from 3/1,000 to
10/1,000 total live births. In the presence of CHD, ven-
tricular septal defects (VSDs) are highly prevalent in new-
borns [1-3]. VSDs account for 30 to 35% of all CHD
detected after birth. Previous studies have identified a* Correspondence: ch2876@chgh.org.tw
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reproduction in any medium, provided the orVSD prevalence of 10 to 16% in fetal tests [1,4,5]. VSDs
were also associated with other heart structural defects,
such as right ventricular outflow tract and left ventri-
cular outflow tract anomalies, as well as some aspects of
Tetralogy of Fallot. Chromosomal anomalies associated
with a VSD include trisomies 21, 13, and 18, deletion in
22q11, and nonchromosomal malformed fetuses [6,7].
The incidence of VSDs is the highest and second highest
in live births and stillbirths, respectively [1]. VSDs are also
the most common CHD diagnosis within the first year of
life and the most frequently detected prenatal heart defect.
VSDs represent one of the major sources of false-negative
diagnoses in the uterus. Improvements in prenatal scree-
ning and VSD diagnosis can reduce neonatal mortality
and morbidity [8,9]. B-mode fetal echocardiography asd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the clinical screening methods used for VSDs [10-12].
Previous studies have proposed fetal Doppler echocardio-
graphy screening as an additional screening tool for VSDs
[13-15]. Other studies indicated a high correlation bet-
ween results obtained using fetal echocardiography and
color Doppler echocardiography, reporting high sensitivity
and specificity, and a low false-positive rate for CHD in
fetal echocardiography examinations [16-19]. Conducting
Doppler assessments of fetal arterial blood flow might in-
crease the rate of identification of fetuses at risk of CHD.
According to previous studies, CHD is associated with a
significantly decreased pulsatility index (PI) in the middle
cerebral artery (MCA) and an increased PI in the umbi-
lical artery (UA) [20-22].
Fetal VSD assessment is a major component of a pre-
natal fetal heart examination, and is a useful primary diag-
nostic and screening tool for fetal CHD or chromosomal
anomalies. In this study, we investigated fetal variations in
VSDs using fetal arterial Doppler assessments to establish
the risk of fetal VSDs in the general population.
Methods
Study participants
The study participants were 2,661 women with singleton
pregnancies who underwent a fetal level II prenatal ultra-
sound examination, including detailed fetal echocardio-
graphy, in one teaching hospital and three obstetric clinics
in Taipei, Taiwan between August 2006 and May 2010. As
part of their prenatal care routine, all women underwent a
prenatal ultrasound (including echocardiography) at 32 to
34 weeks of gestation. All procedures were performed in
accordance with the guidelines of our institutional ethics
committee and the tenets of the Declaration of Helsinki.
All patient information was anonymous. Access to per-
sonal records was approved by the Hospital Human Sub-
jects Review Board at Fu-Jen University, Taipei, Taiwan.
The gestational age (GA) of a fetus was determined ac-
cording to the date of confinement estimated by the pa-
tient. If the estimated date of confinement was unknown,
the difference between the ultrasonically estimated GA
and the determined GA was assumed to be <10 days. For
all fetuses with any associated abnormality, an antenatal
diagnosis was arranged at a medical center within 1 to 2
weeks. The study exclusion criteria included a previous
history of chromosome abnormalities, fetal structural
anomalies or other CHD, and maternal complications.
Ultrasound equipment and intraobserver variability
All fetal examinations were performed using a Volu-
son730ProV ultrasound platform (General Electric Medical
Systems, Milwaukee, WI, USA) with multifrequency trans-
abdominal transducers. A single experienced registered
sonographer collected all scans and fetal measurements.Reliability statistics were used to assess the agreement
of intraobserver reliability among repeated fetal biometry
measurements collected by the same examiner.
Measurement of fetal nasal bone and biometric
examination
Fetal nasal bone length (NBL) was measured in a midsag-
ittal view of the head using appropriate image magnifica-
tion. To prevent measurement error, if the nasal bone was
absent or shortened then the angle of the fetal nose was
maintained at between 45° and 135°. Each increment was
set at a 0.1 mm caliper distance, at the appropriate image
magnification, to maintain accuracy [23].
The biparietal diameter (BPD) was measured on a trans-
verse axial section of the fetal head, which included the
midline falx and the thalami, symmetrically positioned on
either side of the falx from the outer edge of the nearer
parietal bone to the inner edge of the more distant parietal
bone, and the septum pellucidum was visualized at one-
third of the frontal–occipital distance [24].
The plane of the abdominal circumference (AC) was
measured on a transverse section through the fetal abdo-
men. This plane was at the level of the liver and stomach
bubble including the ductus venosus within the point of
bifurcation of the main portal vein into its right and left
branches in the anterior third of the fetal abdomen in the
axial plane 90° to the fetal spine and posterior to the aorta.
Measured from skin to skin, the transverse and anterior–
posterior diameters were first measured as the long or
short axis of an onscreen ellipse, and the circumference
was obtained using elliptical calipers superimposed on the
four points [24]. The single measurement plane of six limb
bones (humerus, ulna, radius, femur, tibia, and fibula) was
on the longest section of each structure. An appropriate
magnification was used for the image to occupy three-
quarters of the screen. The transducer was aligned to the
long axis of the limb bone to obtain the appropriate plane
of the section. The ossified portion of diaphysis was mea-
sured. The cartilaginous ends of the limb bones were ex-
cluded [25].
The estimated fetal body weight (FBW) was calculated
using Hadlock’s formula [26]. This formula involves a
summation of the BPD, AC, and femur length and pro-
vides a number in millimeters. The regression equation
of the estimated FBW is:
Log10 FBWð Þ ¼ 1:4787−0:003343 AC FLð Þ
þ 0:001837 BPDð Þ2 þ 0:0458 ACð Þ
þ 0:158 femur lengthð Þ
Fetal heart assessment and Doppler measurement
The sonographers performed detailed fetal echocardio-
graphic examinations of the 19-week to 24-week level II
Figure 2 Shunt between the right and left ventricles.
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The detailed fetal heart assessment included basic screen-
ing and an extended cardiac scan [27,28]. The standard
fetal echocardiographic evaluation involves employing
all modalities of diagnostic ultrasound, including two-
dimensional gray-scale imaging, and color and Doppler
color flow mapping. The examination included the
standard four-chamber view, the views of the left ventricu-
lar outflow tract and right ventricular outflow tract, the
three-vessel view, and the basal short-axis two-dimensional
B-mode echocardiography image.
Gray-scale imaging was initially performed, followed by
color Doppler flow mapping (Figure 1). The high-pass
filter was set at 100 Hz. The four-chamber view was obser-
ved using real-time scanning, and color Doppler was used
to detect the presence of a VSD during the phase of a
shunt between the right and left ventricles (Figure 2). The
fetuses with VSDs that shunted flow were detected using
two-dimensional color Doppler ultrasound examinations.
The VSDs were recorded to ensure that the septum
was perpendicular to the ultrasound beam, enabling the
flow crossing the septum, indicating a septal defect, to
be detected accurately [29]. For all fetuses with VSDs, a
diagnostic antenatal echocardiographic examination was
arranged at a medical center within 1 to 2 weeks. After de-
livery, the newborn babies with VSDs received a postnatal
echocardiographic examination. In the non-VSD group,
a prenatal ultrasound (including echocardiography) was
performed at 32 to 34 weeks of gestation. A pediatrician
examined the heart sound of all newborn babies.
An ultrasound examination for fetal biometry and a
fetal heart assessment were conducted to exclude struc-
tural abnormalities. Liquor volume assessments, Doppler
blood flow measurements of the UA, and Doppler blood
flow velocity measurements of the MCA were also per-
formed. All fetuses were subjected to Doppler exami-
nation of the MCA. An axial section of the brain,Figure 1 Color Doppler flow mapping.imaged in the BPD biometry plane, was obtained. The
plane was then shifted downward toward the skull base.
The circle of Willis was visualized and the MCA on one
side was examined. The optimal site for recording a
Doppler spectrum is the midpoint of the MCA, approxi-
mately 1 cm from the circle of Willis. The width of the
sample volume was set between 2 and 4 mm. The wall
filter was set as ≤120 Hz. Pulsed wave Doppler analysis
was performed with the angle between the ultrasound
beam and the direction of blood flow maintained as close
to 0 to 25° as possible (Figure 3) [30,31]. The Doppler
spectrum was sampled from a free loop of the umbilical
cord with a wall filter setting >120 Hz (Figure 4) [30]. The
PIs and resistance indices (RIs) of the UA and MCA
Doppler waveform were measured.
In this study, the sensitivity of UA PIs >90% (1.47),
MCA PIs <10% (1.23) and nasal bone length were 36.80%,
20.80% and 19.35%, respectively. The specificity of UA
PIs >90% (1.47), MCA PIs <10% (1.23), and nasal bone
length were 96.71%, 91.52%, and 93.46%, respectively.Figure 3 Middle cerebral artery.
Figure 4 Umbilical artery.
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A statistical analysis was performed using the Statistical
Package for the Social Sciences (Version 13.0 for Windows;
SPSS, Chicago, IL, USA). P <0.05 was considered statisti-
cally significant. The mean, standard deviation, and percen-
tiles of the GA, NBL, limb bone length, estimated FBW,
cardiothoracic area ratio, cardiothoracic circumference ra-
tio, PIs and RIs of the UA, and PIs and RIs of the MCA
were determined. In addition, a logistic regression of a
binary response variable (Y) on a continuous, normally dis-
tributed variable (X) with a sample size of 2,661 observa-
tions achieves 99% power at a 0.05 significance level to
detect a change in Prob(Y = 1) from the value of 0.046 at
the mean of X to 0.067 when X is increased to one stan-
dard deviation above the mean [32].
Results and discussion
In this study, we evaluated 60 fetuses randomly selected
during ultrasound screening. Table 1 presents the meanTable 1 Intraobserver repeatability of fetal biometry and Dop
n Repeat measurements
Nasal bone length 60 2
Biparietal diameter 44 2
Head circumference 44 2
Humerus length 44 2
Radius length 44 2
Ulna length 44 2
Femur length 44 2
Tibia length 44 2
Fibula length 44 2
UA PI 60 2
UA RI 60 2
MCA PI 60 2
MCA RI 60 2
MCA, middle cerebral artery; PI, pulsatility index; RI, resistance index; SE, standard edifferences between the measurements collected using
prenatal ultrasonography and Doppler sonography, and
the accepted Cronbach’s alpha values. Except VSDs, we
excluded 43 cardiac anomaly cases. The prevalence of
all cardiac anomalies was 6.17% in our cohort. Because
most of the parameters in studies change with gesta-
tional age, Table 2 presents the distribution of parame-
ters as multiples of medians.
As shown in Table 3, the overall prevalence of VSDs
in the screened population was 4.66%. A chi-square test
indicated that the prevalence of VSDs exhibited a
borderline statistically significant decrease as the GA in-
creased (P = 0.06). The prevalence of VSDs in the male
and female fetuses showed nonsignificant differences
(4.85% vs. 4.45%, χ2 = 0.15, P = 0.70). After stratifying the
data on GA into six age groups, the male fetuses exhi-
bited a higher prevalence of VSDs than the female
fetuses did in all GA groups except the 19-week to
23-week subgroup. The chi-square test indicated that
the GA-specified prevalence of VSDs was significantly
associated with age in the male (P = 0.04), but not the
female (P = 0.38), fetuses.
Table 4 presents the characteristics of the fetuses with
and without VSDs in the late-second-trimester popula-
tion. Using the two-sample independent t test, we identi-
fied that the GA, NBL, BPD, AC, femur length, tibia
length, fibula length, humerus length, ulna length, radius
length, estimated FBW, UA PI, UA RI, MCA PI, MCA
RI, ratio of the MCA RI to UA PI, and ratio of MCA RI
to UA RI were all significantly associated with VSDs.
We then used a multiple logistic regression model to
evaluate the effects of independent associated risk factors
on VSDs. Table 5 presents the NBLs (odds ratio = 0.69, 95%
confidence interval: 0.55 to 0.87), UA PIs (odds ratio = 8.10,
95% confidence interval: 4.31 to 15.21), and MCA PIs (oddspler assessment














rror (difference in the paired measurements); UA, umbilical artery.
Table 2 Distribution of study parameters (multiples of medians)
19 weeks 20 weeks 21 weeks 22 weeks 23 weeks 24 weeks
Nasal bone length 0.96 0.93 0.95 0.96 0.92 0.90
Biparietal diameter 0.94 0.99 0.98 0.99 0.99 0.97
Head circumference 0.97 0.98 0.98 0.99 0.99 0.98
Abdominal circumference 1.00 0.99 0.98 0.96 0.99 0.99
Femur length 0.99 0.94 0.97 0.97 1.00 0.98
Tibia length 0.98 0.97 0.97 0.98 0.99 0.97
Fibula length 1.00 0.97 0.97 0.98 0.99 0.97
Humerus length 0.95 0.99 0.99 0.98 0.97 0.98
Radius length 0.99 0.96 0.98 0.98 0.98 0.95
Ulna length 1.00 0.99 0.99 0.99 0.99 0.97
Estimated FBW 0.97 0.96 0.96 0.94 0.97 0.99
UA PI 1.60 1.06 1.04 1.06 1.06 1.06
UA RI 1.22 1.05 1.03 1.03 1.01 1.03
MCA PI 0.88 0.95 0.98 0.90 0.92 0.89
MCA RI 0.94 1.00 0.99 0.96 0.98 0.96
MCA/UA PI ratio 0.61 0.93 0.99 0.88 0.99 0.99
MCA/UA RI ratio 0.77 0.98 1.00 0.95 0.96 0.98
FBW, fetal body weight; MCA, middle cerebral artery; MCA/UA PI ratio, ratio of middle cerebral artery resistance index to umbilical artery pulsatility index; MCA/UA
RI ratio, ratio of middle cerebral artery resistance index to umbilical artery resistance index; PI, pulsatility index; RI, resistance index; UA, umbilical artery.
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adjustment for confounding factors.
Other independent variables included the GA, NBL,
BPD, AC, femur length, tibia length, fibula length,
humerus length, ulna length, radius length, estimated
FBW, UA PIs, UA RIs, MCA PIs, MCA RIs, ratio of the
MCA RI to UA PI, and ratio of MCA RI to UA RI, ex-
cepting the cardiothoracic area ratio and cardiothoracic
circumference ratio.
According to our research, few studies have evaluated
the parameters of circulation in fetuses with VSDs in
Taiwan. Therefore, the purposes of our study were to
evaluate the effects of isolated VSDs on fetal arterial
hemodynamics and to determine the prognostic value of
fetal arterial Doppler sonography in fetuses with VSDs.
The prevalence of intrauterine growth restriction in the
VSD and non-VSD groups was estimated as 4.84% and
4.46%, respectively. These results implied that fetuses
with isolated VSDs were significantly smaller than the
fetuses with normal cardiac anatomy. In addition, our
study results indicated that the hemodynamics of the
UA and MCA in all fetuses with CHD differed signifi-
cantly from those of healthy fetuses. These findings sup-
port those of previous studies [20-22]. However, from a
clinical viewpoint, abnormal UA PIs, UA RIs, MCA PIs,
and MCA RIs are no more frequent in fetuses with iso-
lated VSDs than in healthy fetuses. Our results indicated
that the UA PI and the MCA PI represent risk factorsfor fetal VSDs. This finding is consistent with those of
other population-based studies [20,22,33].
In this study, the fetuses with VSDs exhibited signifi-
cantly lower values for fetal biometry and FBW than did
the fetuses without VSDs. In Mari and Deter’s study, re-
ductions in the fetal MCA PI were associated with peri-
natal growth restriction [34]. Lower fetal MCA PI values
indicate that the human fetus responds to hypoxemia by
centralizing blood flow to the brain in a process known
as the brain-sparing effect [35]. A sequence of hemo-
dynamic changes occurs as the fetal condition progres-
sively deteriorates; however, the precise nature of these
changes has not been fully elucidated.
Our study results indicated that the risk of fetal VSDs
decreases with the degree of NBL shortening. VSDs are
the most common lesion in trisomy 21; therefore, identify-
ing fetal VSDs might increase the identification rate of
fetuses at risk of developing Down syndrome [36]. Down
syndrome is strongly associated with the hypoplastic fetal
NBL, and fetal NBL examination is associated with high
sensitivity, high specificity, and a low false-positive rate in
Down syndrome screening [37,38]. In this study, we
followed up the infants with VSDs for 24 months. Most of
the infants’ VSDs were spontaneous closures between 6
and 18 months, and 28.6% (36/124) of the cases were
spontaneous closures after delivery. In previous studies,
the incidence of live-born infants with VSDs ranged
from approximately 1 to 4.36% [39,40]. In addition, the
Table 3 Gender and gestational age specific prevalence of ventricular septal defects among screened subjects (n = 2,661)
GA (weeks) Male Female Total
Screened (n) VSD (n) Prevalence (%) P value for
trend test
Screened (n) VSD (n) Prevalence (%) P value for
trend test
Screened (n) VSD (n) Prevalence (%) P value for
trend test
19+0 to 19+6 34 0 0.00 48 4 8.33 82 4 4.87
20+0 to 20+6 182 11 6.04 0.04 170 7 4.12 0.38 352 18 5.11 0.06
21+0 to 21+6 338 24 7.10 284 11 3.87 622 35 5.63
22+0 to 22+6 382 20 5.23 340 17 5.00 722 37 5.12
23+0 to 23+6 263 7 2.66 270 15 5.56 533 22 4.13
24+0 to 24+6 182 5 2.74 168 3 1.79 350 8 2.29
Total 1,381 67 4.85 1,280 57 4.45 2,661 124 4.66



















Table 4 Characteristics of ventricular septal defect (VSD) among screened subjects (n = 2,661)
Variable Normal (n = 2,537) VSD (n = 124) P value
Mean ± SD 10 to 90% Mean ± SD 10 to 90%
NBL (mm) 6.74 ± 0.87 5.60 to 7.90 6.40 ± 0.79 5.30 to 7.40 <0.0001
BPD (mm) 54.33 ± 9.10 48.00 to 60.00 52.65 ± 4.87 47.12 to 59.70 0.041
HC (mm) 197.34 ± 15.57 177.00 to 218.00 193.94 ± 14.66 175.00 to 213.40 0.017
AC (mm) 177.08 ± 16.15 156.00 to 198.00 171.36 ± 16.12 150.82 to 194.45 <0.0001
Femur length (mm) 37.33 ± 3.86 32.50 to 42.40 35.93 ± 3.78 30.72 to 41.10 <0.0001
Tibia length (mm) 32.92 ± 3.42 28.30 to 37.30 31.90 ± 3.53 27.12 to 36.92 0.001
Fibula length (mm) 32.76 ± 3.33 28.35 to 37.00 31.71 ± 3.27 26.88 to 36.00 0.001
Humerus length (mm) 35.39 ± 3.34 31.00 to 39.70 34.40 ± 3.24 29.94 to 38.70 0.001
Radius length (mm) 30.34 ± 2.94 26.70 to 34.00 29.38 ± 2.70 25.70 to 32.46 <0.0001
Ulna length (mm) 32.92 ± 3.21 28.80 to 37.00 32.07 ± 3.14 28.00 to 36.30 0.004
Estimated FBW (g) 508.75 ± 116.48 364.00 to 666.00 470.74 ± 107.31 343.60 to 608.20 <0.0001
CTAR 0.22 ± 0.12 0.18 to 0.25 0.21 ± 0.03 0.18 to 0.25 0.753
CTCR 0.46 ± 0.06 0.42 to 0.50 0.46 ± 0.03 0.43 to 0.50 0.131
UA PI 1.16 ± 0.22 0.93 to 1.40 1.33 ± 0.34 0.99 to 1.91 <0.0001
UA RI 0.69 ± 0.08 0.60 to 0.78 0.74 ± 0.09 0.64 to 0.86 <0.0001
MCA PI 1.59 ± 0.27 1.26 to 1.90 1.48 ± 0.24 1.18 to 1.82 <0.0001
MCA RI 0.81 ± 0.08 0.72 to 0.91 0.79 ± 0.65 0.71 to 0.87 0.008
MCA/UA PI ratio 1.41 ± 0.34 1.02 to 1.79 1.19 ± 0.38 0.66 to 1.67 <0.0001
MCA/UA RI ratio 1.19 ± 0.18 0.99 to 1.40 1.09 ± 0.18 0.85 to 1.30 <0.0001
AC, abdominal circumference; BPD, biparietal diameter; CTAR, cardiothoracic area ratio; CTCR, cardiothoracic circumference ratio; FBW, fetal body weight; HC, head
circumference; MCA, middle cerebral artery; MCA/UA PI ratio, ratio of middle cerebral artery resistance index to umbilical artery pulsatility index; MCA/UA RI ratio,
ratio of middle cerebral artery resistance index to umbilical artery resistance index; NBL, nasal bone length; PI, pulsatility index; RI, resistance index; SD, standard
deviation; UA, umbilical artery; VSD, ventricular septal defect.
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4.66%, which is higher than the previously reported rates.
A possible reason for this discrepancy is natural fetal loss
or pregnancy termination because of abnormalities or
malformations of the fetus. Research showed that 74% of
isolated fetal VSDs close spontaneously prior to birth [41].
One of the major limitations of this study was the poten-
tial for selection bias caused by the use of a screened
hospital-based population. However, because of our rela-
tively large sample size, we were able to achieve statistically
significant conclusions. Secondly, we did not explicitly
consider the sensitivity and specificity of the screening
tests. Although the agreement of interobserver reliability




NBL −0.37 0.12 0.69
UA PI 2.09 0.32 8.10
MCA PI −1.37 0.38 0.25
MCA, middle cerebral artery; NBL, nasal bone length; PI, pulsatility index; UA, umbilidentification still could have occurred. Thirdly, from the
screening cost viewpoint, it is very difficult to follow all of
the study cases with postnatal echocardiography. Finally,
we collected our measurements at a single point in time,
which could have eliminated the influence of various long-
term demographic or biochemical factors on the risk of
VSDs. Further longitudinal investigations to confirm our
study findings are warranted.Conclusions
In this study we evaluated the NBL, MCA PI, and UA
PI of fetuses with VSDs in the late-second trimester of
pregnancy. Our results indicate that the evaluation ofentricular septal defects among screened fetuses
Ventricular septal defects (yes vs. no) P value
atio 95% confidence interval
0.55 to 0.87 0.001
4.31 to 15.21 <0.0001
0.12 to 0.54 <0.0001
ical artery; SE, standard error.
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screening of fetal VSDs.
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